News | Radiation Therapy | February 07, 2017

Northern Ireland cancer center will now be able to perform fully independent, measurement-based quality assurance for IMRT and VMAT treatments

IBA, Dolphin Online Ready Patient QA and Monitoring solution, radiotherapy, North West Cancer Centre, Londonderry, Northern Ireland, first in U.K.

February 7, 2017 — IBA (Ion Beam Applications S.A.) recently announced the first clinical implementation of its Dolphin Online Ready Patient QA and Monitoring solution in the United Kingdom.

With the use of Dolphin attached to the hospital’s TrueBeam treatment machine, the team at the North West Cancer Centre in Londonderry, Northern Ireland, set a new standard for high quality cancer therapy and a more efficient patient quality assurance (QA) process.

“With Dolphin we can perform fully independent, measurement-based quality assurance of our most advanced IMRT [intensity modulated radiation therapy] and VMAT [volumetric arc therapy] treatments quickly and confidently.” said Andrew Reilly, M.D., head of radiotherapy physics at the North West Cancer Centre, Londonderry. He continued, “Being so straightforward to use, it allows us to plan to the capabilities of the treatment machines, rather than limiting what we do because legacy verification processes cannot keep up. This ensures our clinicians can offer the best possible care to their patients.”

Wendy Hyland, M.D., radiotherapy physicist added, “The measurement process is so easy I can spend more time thinking about what the results mean rather than worrying about the measurements themselves.”

Dolphin is a complete solution that offers a higher capability to detect and verify possible treatment dose discrepancies compared to conventional QA solutions, according to IBA, thus contributing to a more efficient and safer radiation therapy. This improvement is based on Dolphin’s significantly higher treatment dose measurement resolution.

Highly complex IMRT and rotational treatment plans are delivered and measured with the Dolphin transmission detector prior to each patient treatment. A sophisticated TPS-Class software allows verification of dose deviations in 3-D patient anatomy between the plan and actual delivered dose measured with Dolphin.

The hospital’s patient QA workflow efficiency is increased with Dolphin’s “plug and play” wireless setup and its automatic verification software displaying instant QA results.

The Dolphin solution including the detector and the software is online-ready and currently used for pre-treatment QA. The system will be capable of measuring the actual patient treatment dose in online mode, fraction by fraction. The online capability is currently pending release.

For more information: www.iba-dosimetry.com

Related Content

News | Quality Assurance (QA)

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
Feature | Radiation Therapy

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Radiation Therapy

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
News | Lung Imaging

September 23, 2021 — The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center ...

Time September 23, 2021
arrow
News | Radiation Oncology

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
News | Radiation Oncology

September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means ...

Time September 20, 2021
arrow
Subscribe Now